Details of the Drug Reposition

General Information of This Drug (ID: DMCXTM0)

Drug Name
SB623   DMCXTM0
Drug Type
Cell therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ischemic stroke DISYV7YJ 8B11.5Z Phase 2 [1]
Traumatic brain injury DISN8K9H NA07.Z Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02448641) Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke (ACTIsSIMA). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT02416492) A Study of Modified Stem Cells in Traumatic Brain Injury (TBI) (STEMTRA). U.S. National Institutes of Health.